Asit Parikh, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 5,000 shares at $7.73 ($39K) on 2023-02-13, disclosed to the SEC on 2023-02-14.
Open-market purchase of $39k PHAT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| PHAT | BUY | 2024-12-16 | $162K | — | Filing → |
| PHAT | BUY | 2023-11-08 | $59K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $8K | — | Filing → |